or Try an Advanced Search...

    Technical Analysis for ARTL - Artelo Biosciences, Inc.

    Grade Last Price % Change Price Change
    C 1.15 3.60% 0.04
    ARTL closed up 3.6 percent on Wednesday, November 20, 2024, on 1.21 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Flat Flat
    Historical ARTL trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Crossed Above 50 DMA Bullish 0.00%
    Calm After Storm Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Fell Below 20 DMA Bearish 3.60%
    Fell Below 50 DMA Bearish 3.60%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.60%
    Inside Day Range Contraction 3.60%
    Slingshot Bearish Bearish Swing Setup -5.74%
    Bullish Engulfing Bullish -5.74%
    Older End-of-Day Signals for ARTL ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 18 hours ago
    Possible Inside Day about 18 hours ago
    Rose Above 20 DMA about 18 hours ago
    60 Minute Opening Range Breakout about 18 hours ago
    Up 5% about 18 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ARTL Chart by TradingView
    Basic chart:

    Profile

    Artelo Biosciences, Inc. is a San Diego-based biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting the endocannabinoid system. Artelo is rapidly advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including cancer, pain, and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the company applies leading edge scientific, regulatory, and commercial discipline to develop high-impact therapies.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Pain Pharmacy Medication Inflammation Cannabinoid

    Is ARTL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 18 Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit
    Nov 13 Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium
    Nov 12 Artelo Biosciences GAAP EPS of -$0.35 beats by $0.44
    Nov 12 Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
    Nov 5 Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” Program
    Oct 9 Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16th
    Sep 4 Artelo Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    Aug 13 Artelo Biosciences GAAP EPS of -$0.75
    Aug 13 Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
    Jul 15 Artelo stock jumps 13% after FDA okays ART26.12 Phase 1 study
    See more ARTL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.75
    52 Week Low 1.0
    Average Volume 18,119
    200-Day Moving Average 1.33
    50-Day Moving Average 1.15
    20-Day Moving Average 1.16
    10-Day Moving Average 1.15
    Average True Range 0.10
    RSI (14) 49.75
    ADX 21.62
    +DI 23.19
    -DI 13.16
    Chandelier Exit (Long, 3 ATRs) 1.03
    Chandelier Exit (Short, 3 ATRs) 1.31
    Upper Bollinger Bands 1.26
    Lower Bollinger Band 1.06
    Percent B (%b) 0.46
    BandWidth 17.67
    MACD Line -0.01
    MACD Signal Line 0.00
    MACD Histogram -0.0047
    Fundamentals Value
    Market Cap 3.67 Million
    Num Shares 3.19 Million
    EPS -3.33
    Price-to-Earnings (P/E) Ratio -0.35
    Price-to-Sales 0.00
    Price-to-Book 0.32
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.24
    Resistance 3 (R3) 1.24 1.21 1.23
    Resistance 2 (R2) 1.21 1.19 1.21 1.22
    Resistance 1 (R1) 1.18 1.17 1.20 1.18 1.21
    Pivot Point 1.15 1.15 1.16 1.15 1.15
    Support 1 (S1) 1.12 1.13 1.14 1.12 1.09
    Support 2 (S2) 1.09 1.11 1.09 1.08
    Support 3 (S3) 1.06 1.09 1.08
    Support 4 (S4) 1.06